Correction to

Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment (Journal of Neuro-Oncology, (2018), 137, 1, (171-177), 10.1007/s11060-017-2709-0)

Wenyin Shi, Erik S. Blomain, Joshua Siglin, Joshua D. Palmer, Tu Dan, Yang Wang, Maria Werner-Wasik, Jon Glass, Lyndon Kim, Voichita Bar Ad, Deepak Bhamidipati, James J. Evans, Kevin Judy, Christopher J. Farrell, David W. Andrews

Research output: Contribution to journalComment/debate

Abstract

The fourth author’s name was incorrect in the initial online publication. The original article has been corrected.

Original languageEnglish (US)
Number of pages1
JournalJournal of Neuro-Oncology
Volume137
Issue number1
DOIs
StatePublished - Mar 1 2018

Fingerprint

Glioma
Names
Publications
Therapeutics
Re-Irradiation
Bevacizumab

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this

Correction to : Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment (Journal of Neuro-Oncology, (2018), 137, 1, (171-177), 10.1007/s11060-017-2709-0). / Shi, Wenyin; Blomain, Erik S.; Siglin, Joshua; Palmer, Joshua D.; Dan, Tu; Wang, Yang; Werner-Wasik, Maria; Glass, Jon; Kim, Lyndon; Bar Ad, Voichita; Bhamidipati, Deepak; Evans, James J.; Judy, Kevin; Farrell, Christopher J.; Andrews, David W.

In: Journal of Neuro-Oncology, Vol. 137, No. 1, 01.03.2018.

Research output: Contribution to journalComment/debate

Shi, Wenyin ; Blomain, Erik S. ; Siglin, Joshua ; Palmer, Joshua D. ; Dan, Tu ; Wang, Yang ; Werner-Wasik, Maria ; Glass, Jon ; Kim, Lyndon ; Bar Ad, Voichita ; Bhamidipati, Deepak ; Evans, James J. ; Judy, Kevin ; Farrell, Christopher J. ; Andrews, David W. / Correction to : Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment (Journal of Neuro-Oncology, (2018), 137, 1, (171-177), 10.1007/s11060-017-2709-0). In: Journal of Neuro-Oncology. 2018 ; Vol. 137, No. 1.
@article{15de31e2e0fc4d05a54293bc3b7064c0,
title = "Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment (Journal of Neuro-Oncology, (2018), 137, 1, (171-177), 10.1007/s11060-017-2709-0)",
abstract = "The fourth author’s name was incorrect in the initial online publication. The original article has been corrected.",
author = "Wenyin Shi and Blomain, {Erik S.} and Joshua Siglin and Palmer, {Joshua D.} and Tu Dan and Yang Wang and Maria Werner-Wasik and Jon Glass and Lyndon Kim and {Bar Ad}, Voichita and Deepak Bhamidipati and Evans, {James J.} and Kevin Judy and Farrell, {Christopher J.} and Andrews, {David W.}",
year = "2018",
month = "3",
day = "1",
doi = "10.1007/s11060-018-2744-5",
language = "English (US)",
volume = "137",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - Correction to

T2 - Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment (Journal of Neuro-Oncology, (2018), 137, 1, (171-177), 10.1007/s11060-017-2709-0)

AU - Shi, Wenyin

AU - Blomain, Erik S.

AU - Siglin, Joshua

AU - Palmer, Joshua D.

AU - Dan, Tu

AU - Wang, Yang

AU - Werner-Wasik, Maria

AU - Glass, Jon

AU - Kim, Lyndon

AU - Bar Ad, Voichita

AU - Bhamidipati, Deepak

AU - Evans, James J.

AU - Judy, Kevin

AU - Farrell, Christopher J.

AU - Andrews, David W.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - The fourth author’s name was incorrect in the initial online publication. The original article has been corrected.

AB - The fourth author’s name was incorrect in the initial online publication. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85042382547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042382547&partnerID=8YFLogxK

U2 - 10.1007/s11060-018-2744-5

DO - 10.1007/s11060-018-2744-5

M3 - Comment/debate

VL - 137

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -